INS and metabolic dysfunction-associated steatotic liver disease: The RAS has been implicated in the pathogenesis of NAFLD, and research has demonstrated a role for RAS intermediates in hepatic glucose metabolism, lipid processing, and insulin sensitivity [28,29,30].